Search company, investor...
Viridos company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Grant | Alive

Total Raised


About Viridos

Viridos is dedicated to developing and commercializing genomic-driven solutions to address global energy and environmental challenges. The company's main research and business programs are focused on the following major bioenergy areas: designing advanced biofuels with superior properties compared to ethanol and biodiesel; harnessing photosynthetic organisms to produce value-added products directly from sunlight and carbon dioxide; developing new biological solutions to increase production and/or recovery rates of subsurface hydrocarbons and developing high-yielding, more disease resistant and economic feedstocks. It was founded in 2005 and is based in La Jolla, California.

Viridos Headquarters Location

11149 North Torrey Pines Road

La Jolla, California, 92037,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Viridos

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Viridos in 2 CB Insights research briefs, most recently on Aug 31, 2021.

Expert Collections containing Viridos

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Viridos is included in 3 Expert Collections, including Synthetic Biology.


Synthetic Biology

305 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.


Renewable Energy

2,837 items

Includes companies working on technology to support renewable energy generation.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Viridos Patents

Viridos has filed 134 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Genetics
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Transcription factors, Genetics, Gene expression, Biotechnology


Application Date


Grant Date



Related Topics

Molecular biology, Transcription factors, Genetics, Gene expression, Biotechnology



Latest Viridos News

$32.9 Billion Worldwide Synthetic Biology Industry to 2027 - Featuring Amyris, Codexis and Danaher Among Others -

Jul 13, 2022

Viridos Inc. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor. Synthetic biology refers to a field of research involving the construction and designing of new biological entities, such as enzymes, genetic circuits, and cells or redesigning organisms for valuable purposes by engineering them to have unique abilities. It combines the chemical synthesis of deoxyribonucleic acid (DNA) with genomics to enable researchers to manufacture cataloged DNA sequences and assemble them into new genomes. It assists in improving the environment by discovering novel ways to reduce pollution, making industrial processes for chemical synthesis sustainable, and removing the need for damaging farming practices by making better fertilizers. In recent years, improvements in the speed and cost of DNA synthesis have enabled scientists in designing and synthesizing modified bacterial chromosomes, which can be utilized in the production of advanced biofuels, bio-products, renewable chemicals, and bio-based specialty chemicals. This, in confluence with increasing investments in synthetic biology, represents one of the key factors impelling the growth of the market. Moreover, synthetic biology is employed in the healthcare sector as it can help improve diagnosis and develop better treatment options for numerous diseases, directed only towards the site of disease without causing any adverse effects. Besides this, there is a significant rise in the use of genetically engineered viruses to correct defective genes in patients with inherited diseases like epidermolysis bullosa or severe combined immune deficiency (SCID). Apart from this, tools for performing synthetic biology are becoming more accessible, and the internet penetration has enabled ideas and information to be freely exchanged, which is facilitating the market growth. Furthermore, significant growth in the healthcare sector and the rising number of synthetic biology research entities worldwide are positively influencing the market. Key Questions Answered in This Report: How has the global synthetic biology market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global synthetic biology market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the technology? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global synthetic biology market and who are the key players? What is the degree of competition in the industry? Key Topics Covered:

Viridos Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Viridos Rank

  • When was Viridos founded?

    Viridos was founded in 2005.

  • Where is Viridos's headquarters?

    Viridos's headquarters is located at 11149 North Torrey Pines Road, La Jolla.

  • What is Viridos's latest funding round?

    Viridos's latest funding round is Grant.

  • How much did Viridos raise?

    Viridos raised a total of $75M.

  • Who are the investors of Viridos?

    Investors of Viridos include California Governor's Office of Business and Economic Development, Lung Biotechnology, Threshold Ventures, ExxonMobil, Life Technologies Corporation and 8 more.

  • Who are Viridos's competitors?

    Competitors of Viridos include Lynntech, Amyris, Codexis, Evolutionary Genomics, TerraVia and 12 more.

You May Also Like

Tethys Research

Tethys Research, LLC is a Bangor, ME based company that has received a grant(s) from the Department of Energy's SBIR/STTR program. The abstract(s) for these grant award(s) are provided as well since they provide insights into Tethys Research, LLC's business and areas of expertise. This project will develop processes to use the enzyme in pulp mills and forest biorefineries to produce raw materials for chemicals and biofuels. It also clones the enzyme for cost-effective large-scale production. Microorganisms that make novel enzymes to help separate wood components in an efficient and environmentally friendly manner have been developed. This project isolates one of these enzymes so that an enzyme-assisted pulping process can be designed to economically use forest biomass for chemicals and fuel.

New Energy Solutions

New Energy Solutions has developed alternative fuel technology that includes:-Providing clean energy designed to power systems which can be fueled from renewable energy sources instead of fossil fuels-Developing and integrating green energy technology concepts in the field of alternative fuels created from biomass products -Changing the outlook for biomass energy systems to further protect the company's enviroment

EnerTech Environmental

EnerTech Environmental is a renewable energy company focused on the development and commercialization of clean combustion technologies for biosolids (sewage sludge) and other organic wastes. EnerTech's patented SlurryCarb process aims to cleanly and economically converts high-moisture wastes into a high-grade renewable fuel, with significant cost savings over alternative options. Biosolids and other feedstocks undergo a molecular rearrangement that transforms these high-moisture materials into a renewable fuel suitable for the replacement of fossil fuels. By processing biosolids as a fluid, the technology aims to provide savings in both capital and operating costs. The resulting fuel, called E-Fuel, is a clean, renewable fuel that is an excellent replacement for fossil fuels. As a renewable fuel, E-Fuel produces essentially zero net greenhouse gas emissions.

ZeroPoint Clean Technology

ZeroPoint Clean Tech deploys biomass solutions to make renewable energy and sequester carbon. ZeroPoint has a modular, multi-feedstock gasification technology built to international code. The ZeroPoint solution is built with OEM components by the world's highest quality manufacturers. Skid mounted equipment is packaged into turnkey plants and delivered with leading engineering, procurement and construction firms.


Freepower develops small scale turbine technology.

American Biodiesel

American Biodiesel, dba Community Fuels, is an advanced biofuel producer. The company produces among the highest quality biomass-based diesel fuels available - which qualifies as an Advanced Biofuel through the Environmental Protection Agency (EPA), and its own fuel standard closely mirrors the requirements of multiple major oil companies and exceeds the Federal fuel standard (ASTM Standard).

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.